These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10208721)

  • 21. A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines.
    Barkoff AM; Guiso N; Guillot S; Xing D; Markey K; Berbers G; Mertsola J; He Q
    J Immunol Methods; 2014 Jun; 408():142-8. PubMed ID: 24925807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WHO Working Group meeting on standardization of acellular pertussis vaccines: Potency assay Beijing, China, 7-9 November 2007.
    Knezevic I; Baca-Estrada M; Xing DK; Lei D;
    Vaccine; 2008 Jul; 26(32):3960-8. PubMed ID: 18514369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Isolation of hemolytic cultures of Bordetella pertussis intended for the production of acellular pertussis preparations and the characterization of their biological properties].
    Miriasova LV; Vasnak'ian IA; Kopaeva TV; Remova TN; Kozhevnikova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):15-8. PubMed ID: 2552711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
    Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
    Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acellular pertussis vaccines].
    Finger H; Wirsing von König CH
    Immun Infekt; 1992 Dec; 20(6):188-91. PubMed ID: 1490723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
    Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International collaborative study: evaluation of proposed International Reference Reagent of pertussis antiserum (mouse) 97/642.
    Gaines Das R; Xing D; Rigsby P; Newland P; Corbel M
    Biologicals; 2001 Jun; 29(2):137-48. PubMed ID: 11580218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acellular pertussis vaccine].
    Wiedermann G; Ambrosch F; Vanura H
    Wien Med Wochenschr; 1991; 141(12):270-2. PubMed ID: 1949820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of acellular pertussis vaccines].
    Wirsing von König CH; Finger H
    Immun Infekt; 1995 Aug; 23(4):125-9. PubMed ID: 7558115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of acellular pertussis vaccines.
    Hallander H; Reizenstein E
    Biologicals; 1994 Dec; 22(4):391-5. PubMed ID: 7779367
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of toxicities of acellular pertussis vaccine with whole cell pertussis vaccine in experimental animals.
    Sato Y; Sato H
    Dev Biol Stand; 1991; 73():251-62. PubMed ID: 1778317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities.
    Halperin SA; Barreto L; Eastwood BJ; Law B; Roberts EA
    Arch Pediatr Adolesc Med; 1994 Nov; 148(11):1220-4. PubMed ID: 7921131
    [No Abstract]   [Full Text] [Related]  

  • 33. Acellular pertussis vaccines and complement killing of Bordetella pertussis.
    Weiss AA; Patton AK; Millen SH; Chang SJ; Ward JI; Bernstein DI
    Infect Immun; 2004 Dec; 72(12):7346-51. PubMed ID: 15557666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of respiratory model employing conventional NIH mice to access the immunity induced by cellular and acellular pertussis vaccines.
    Dias AA; Boller MA; Werneck LM; Hirata Junior R; Mattos-Guaraldi AL
    Mem Inst Oswaldo Cruz; 2006 Nov; 101(7):749-54. PubMed ID: 17160282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice.
    Ausiello CM; Lande R; Stefanelli P; Fazio C; Fedele G; Palazzo R; Urbani F; Mastrantonio P
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):637-42. PubMed ID: 12853397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J; Ruiz Puente J; González Pacheco M
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract]   [Full Text] [Related]  

  • 38. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
    Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
    Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines.
    Guiso N; Boursaux-Eude C; Weber C; Hausman SZ; Sato H; Iwaki M; Kamachi K; Konda T; Burns DL
    Vaccine; 2001 Apr; 19(23-24):3248-52. PubMed ID: 11312021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bordetella pertussis fimbriae (Fim): relevance for vaccines.
    Gorringe AR; Vaughan TE
    Expert Rev Vaccines; 2014 Oct; 13(10):1205-14. PubMed ID: 25102891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.